Patents Represented by Attorney, Agent or Law Firm Danica L. Hostettler
  • Patent number: 6489296
    Abstract: A method of treatment for human patients with an acquired hypercoagulable state or acquired protein C deficiency associated with sepsis, purpura fulminans, meningococcal sepsis, bone marrow and other transplantations, severe burns, pregnancy, major surgery, severe trauma, or ARDS, which comprises administering activated protein C providing a highly selective therapeutic agent with a low potential for causing bleeding complications.
    Type: Grant
    Filed: May 10, 2000
    Date of Patent: December 3, 2002
    Assignee: Eli Lilly and Company
    Inventors: Brian William Grinnell, Daniel Lawrence Hartman, Sau-Chi Betty Yan